Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again

investors.com/news/technology/dianthus-therapeutics-stock-argenx-vyvgart

Shares of Dianthus Therapeutics surged Monday after the company's autoimmune disease treatment succeeded in a midstage study.
The post Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-09-08 17:17:06.
The Entire Business World on a Single Page. Free to Use →